ChristiaanWSchiepersMDPhD
Nuclear Medicine • Los Angeles, CAProfessor, Molecular & Medical Pharmacology, University of California Los Angeles David Geffen SOM
Are you Dr. Schiepers?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 42 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 UCLA Medical Plz
Suite B114
Los Angeles, CA 90095Phone+1 310-983-1439Fax+1 310-206-4899- Is this information wrong?
Summary
- Dr. Christiaan Schiepers, MD is a board certified nuclear medicine physician in Los Angeles, California. He is currently licensed to practice medicine in California. He is a Professor at University of California Los Angeles David Geffen SOM.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Radiology-Diagnostic, 1989 - 1990
University of Southern California/LAC+USC Medical CenterResidency, Nuclear Medicine, 1987 - 1989
Albany Medical CenterFellowship, Cardiovascular Disease, 1986 - 1987- Albany Medical CenterResidency, Internal Medicine, 1984 - 1986
Utrecht University Faculty of MedicineClass of 1982
Certifications & Licensure
CA State Medical License 1988 - 2026- American Board of Nuclear Medicine Nuclear Medicine
Clinical Trials
- The Biodistribution of 1-L-(2 Deoxy-2,- 18 Fluoroarabinofuranosyl) Cytosine ([18F]L-FAC) in Healthy Subjects and Patients With Cancer, Autoimmune and Inflammatory Diseases Start of enrollment: 2008 May 01
- The Biodistribution of 1-[2 Deoxy-2, -18 Fluroarabinfuranosyl]Cytosine [18FAC] in Healthy Subjects and Patients With Cancer, Autoimmune/Inflammatory Diseases Start of enrollment: 2007 Nov 01
- 68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access)
Publications & Presentations
PubMed
- 9 citationsQuantitative bone scan lesion area as an early surrogate outcome measure indicative of overall survival in metastatic prostate cancer.Matthew S. Brown, Grace Kim, Gregory H. Chu, Bharath Ramakrishna, Martin Allen-Auerbach, Cheryce P. Fischer, Benjamin D. Levine, Pawan Gupta, Christiaan Schiepers, Jon...> ;Journal of Medical Imaging. 2018 Jan 11
- 23 citationsMost of the Intended Management Changes After 68Ga-DOTATATE PET/CT Are Implemented.Jeremie Calais, Johannes Czernin, Matthias Eiber, Wolfgang P. Fendler, Jeannine Gartmann, Anthony P. Heaney, Andrew Eugene Hendifar, Joseph R. Pisegna, J. Randolph Hec...> ;Journal of Nuclear Medicine. 2017 May 4
- 16 citationsHuman Biodistribution and Radiation Dosimetry of 18F-Clofarabine, a PET Probe Targeting the Deoxyribonucleoside Salvage Pathway.Martin Barrio, Claudio Spick, Caius G. Radu, Michael Lassmann, Uta Eberlein, Martin Allen-Auerbach, Christiaan Schiepers, Roger Slavik, Johannes Czernin, Ken Herrmann> ;Journal of Nuclear Medicine. 2017 Mar 1
- Join now to see all
Press Mentions
Newly Developed PSG Score Improves Patient Selection for PSMA Radiopharmaceutical TherapyApril 20th, 2023
